Return to homepagePandemic Pact

Sex as a Biological Variable Supplement - Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: Supplement to P03280

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $37,500

  • Funder

    Canadian Institutes of Health Research (CIHR)

  • Principal Investigator

    Ali Mirazimi, Josef Penninger, Arthur Samuel Slutsky, Haibo Zhang

  • Research Location

    Canada

  • Lead Research Institution

    Keenan Research Centre (Toronto, ON)

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract